IRVING, Texas April 16, 2018 (GLOBE NEWSWIRE) -- Exela Technologies, Inc.(“Exela”) (NASDAQ:XELA), one of the largest global providers of platforms for Business Process Automation (“BPA”), announced today that Ex-Sigma 2 LLC, a stockholder of Exela(the “Selling Stockholder”), closed the previously announced underwritten secondary offering of 7,000,000 shares of Exela’s common stock at a price of $5.00 per share. The Selling Stockholder has also granted the underwriters the option for a period of up to 30 days to purchase up to 1,050,000 shares of Exela common stock to cover over-allotments, if any. Exela did not sell any shares of common stock in, and did not receive any proceeds from, the offering.
Morgan Stanley and RBC Capital Markets served as joint lead bookrunning managers and Cantor and Nomura also served as joint bookrunning managers in the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.Exela previously filed a registration statement (including prospectus) (File No. 333-219494) with the U.S. Securities and Exchange Commission(“SEC”), which was declared effective on October 2, 2017. A prospectus supplement relating to the offering has been filed with the SEC on April 13, 2018.
The offering was made by means of a prospectus supplement and the accompanying prospectus. Before you invest, you should read the registration statement, prospectus and prospectus supplement Exela has made available with the SEC for information about Exela and the offering.You may obtain these documents, including the final prospectus supplement, when available, free of charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus and preliminary prospectus supplement may be obtained from the office of Morgan Stanley, Attention: Prospectus Department,180 Varick Street, 2nd Floor, New York,NY 10014 or RBC Capital Markets, LLC, Attention Equity Syndicate,200 Vesey Street 8th Floor,New York,NY 10281-8098, or by telephone at (877) 822-4089 or by email at equityprospectus@rbccm.com.
About Exela
Embracing complexity. Delivering simplicity.Exela is a global business process automation leader combining industry-specific and industry-agnostic enterprise software and solutions with decades of experience. Our BPA suite of solutions are deployed across banking, healthcare, insurance and other industries to support mission-critical environments.
Exela partners with customers to improve user experience and quality through operational efficiency.Exela serves over 3,500 customers across more than 50 countries, through a secure, cloud-enabled global delivery model. We are 22,000 employees strong at nearly 1,100 onsite customer facilities and more than 150 delivery centers located throughout the Americas, Europe & Asia. Our customer list includes 60% of the Fortune® 100, along with many of the world’s largest retail chains, banks, law firms, healthcare insurance payers and providers and telecom companies. Find out more at www.exelatech.com
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, the estimated or anticipated future results and benefits of the
Contact:
Jim Mathias
W: http://investors.exelatech.com
T: +1 972-821-5808
Source: Exela Technologies, Inc.